Accelerating Coronavirus Testing Solutions (A.C.T.S.) Advisory Panel
Massachusetts understands the gaps that exist in the SARS-CoV-2 testing environment. To accelerate impact during this critical time, the Center solicited proposals to improve testing solutions and address bottlenecks in the testing supply chain. The A.C.T.S. program leverages Massachusetts’ R&D capabilities and innovation infrastructure to accelerate the development of innovative solutions that hinders our ability to quickly and effectively combat and contain the COVID-19 pandemic.
As part of this effort, the MLSC solicited the assistance of outstanding experts across multiple disciplines to serve on the A.C.T.S. Advisory Panel. The panel provides tremendous credibility to our investment portfolio by providing their expertise and talent to help us identify, support, and fund novel innovations and solutions for SARS-CoV-2 testing.
Assistant Professor, Department of Pathology, BIDMC Associate Director, Clinical Microbiology
Beth Israel Deaconess Medical Center
Vice Chancellor for Research and Economic Development
Associate Professor, Dept of Biomedical and Nutritional Sciences
Professor of Health Sciences and Technology (MIT) and Professor of Microbiology and Immunobiology (HMS)
Massachusetts Institute of Technology and Harvard Medical School
Senior Research Scientist, Infectious Disease and Microbiome Program
Senior Research Scientist
Director, Licensing and Strategic Alliances, Office of Technology Licensing
Industry & Certificate Director, System Design & Management
Massachusetts Institute of Technology
Deputy Director and Sr Project Manager, Boston Biomedical Innovation Center
Mass General Brigham
Market Sector Leader
Mass General Brigham
Professor of Medicine, Division of Infectious Diseases and Immunology
UMass Medical School
Mary Ann Picard
Director of Operations
Founder and CEO
Senior Licensing Officer
UMass Medical School – Bridge
Director, IALS and Clinical Professor, BMB
Surgeon and Health Policy Researcher, Dept. of Surgery (BIDMC) and Assistant Professor, Dept. of Health Policy and Management (HSPH)
Beth Israel Deaconess Medical Center and Harvard School of Public Health
VP, Business Development
Associate Professor, Dept. of Biological Chemistry and Molecular Pharmacology and Pediatrics, HMS Investigator, PCMM, BCH Associate Faculty, Wyss Institute
Harvard Medical School and Wyss Institute
Chairman, Department of Medicine (BIDMC) and Professor of Medicine (HMS)
Beth Israel Deaconess Medical Center and Harvard Medical School
Biomanufacturing Advisory Panel
Massachusetts recognizes that as new innovative therapeutic modalities are being developed, a biomanufacturing bottleneck exists keeping therapies from patients. As the life science innovation capital of the world, home to hundreds of companies pioneering innovative therapies and treatments, Massachusetts is well poised to lead in developing these critical biomanufacturing innovations. The Building Breakthroughs Capital Call was designed to provide grants for capital projects in Massachusetts by enabling and supporting biomanufacturing innovation.
As part of this effort, the Massachusetts Life Sciences Center solicited the assistance of outstanding experts to serve on a Biomanufacturing Advisory Panel. The advisory panel provides tremendous credibility to our investment portfolio. Peer Reviewers provide their experience and talent to help us identify highly promising technologies, companies, and collaborative efforts for investment.
Alfred W. Boyle, Ph.D.
Senior Vice President Technical Operations
Jie Chen, M.D.
VP of CMC Operation
Rohan Patil, Ph.D.
Principal Scientist, Bioprocess Development
Philip G. Vanek, Ph.D.
GM, Cell and Gene Therapy Strategy
Data Science Review Panel
Massachusetts recognizes that the role of data sciences in life sciences innovation has evolved rapidly and, if harnessed, has the potential to catalyze innovation at unprecedented rates. The digital transformation is taking place across the globe in various industries. Investment in generating datasets and training data scientists for life science research is required to sustain the Massachusetts global leadership position in life science innovation.
The Bits to Bytes Capital Call was designed to provide grants for capital projects in Massachusetts by enabling and supporting the generation and analysis of large datasets to answer pressing life science questions and to attract and train data scientists in the Commonwealth.
As part of this effort, the MLSC solicited the assistance of outstanding experts to serve on a Data Science Review Panel. The review panel provides tremendous credibility to the Massachusetts Life Sciences Center’s investment portfolio. Peer Reviewers provide their experience and talent to help us identify highly promising technologies, companies, and collaborative efforts for investment.
Research Associate in Pediatrics
Boston Children’s Hospital
Brigham and Women’s Hospital
Beth Israel Deaconess Center
Chief Digital Health
Head, Computational Sciences and Next Generation Analytics
Associate Professor, Director of Operations, Center for Microbiome Research
Scientific Director for Harvard Medical School Research Cores and Technology, Director ICCB-Longwood Screening Facility, Assistant Professor of Department of Radiology (MGH) & Department of Biological Chemistry and Molecular Pharmacology
Massachusetts Green High Performance Computing Center
Professor, Computer Sciences
Technology Research Director
Innovation Leader for Cell Therapy Technologies
GE Life Sciences
Research Associate Professor, College of Engineering – Bioinformatics Research Unit
Shannan Ho Sui
Senior Research Scientist, Department of Biostatistics
Harvard T.H. Chan School of Public Health
Massachusetts Next Generation Initiative Executive Coaches
Increasing the number of successful entrepreneurs is in the best interest of the entire life science industry. Gender parity is not only about equal representation. It is about a strong business case that supports a diverse ecosystem. Launched in 2017, the Massachusetts Next Generation Initiative (MassNextGen) is a five year, over $2 million commitment to ensure greater gender parity in the next generation of life science entrepreneurs.
Each year, following a competitive program, women-led early-stage life science companies will be awarded a year-long customized package of support, which includes non-dilutive grant funding and access to a network of seasoned Executive Coaches.
The Massachusetts Life Sciences Center has leveraged the region’s substantial network of seasoned entrepreneurs, investors, and life science experts to create an executive coaching network that selects each year’s winners based on a set of criteria including, but not limited to, the level of involvement of women in the conception, strategy and execution of the company, the proposed use of funding and feasibility and promise of the business plan and technology.
Co-Founder and CEO
Altrix Bio, Inc.
Vice President of Market Access
Certified Business/Executive Coach
Focal, Point Coaching
CEO and Co-Founder
Partners Innovation Fund
Digital Business Development and Licensing
Mary Ann Picard
Director of Operations
Founder and CEO
Senior Vice President, Global BD and Alliance Management
Digital Business Development & Licensing, Global Business Development & Licensing
Founder and CSO
Meet the dedicated staff committed to supporting the growth and development of the life sciences through innovative programming and initiatives.
Board of Directors
Meet the Board of Directors responsible for the financial health of the agency and its investment in life sciences economic and workforce development.
Meet the Biomanufacturing Advisory Panel, the MassNextGen Executive Coaches, the Data Science Review Panel, and the A.C.T.S. Advisory Panel.